Director/PDMR Shareholding

RNS Number : 7731N
GlaxoSmithKline PLC
02 February 2016
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 2 February 2016 of the following increases in the notional allocation of GSK American Depositary Shares (ADSs) on 29 January 2016, at a price of $41.29 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401(K) plan:

 

 

Director/PDMR

 

Number of ADSs

 

Dr M M Slaoui

 

26

 

 

 

 

Connected Person

 

Number of ADSs

 

Dr K Slaoui (Connected Person of Dr M M Slaoui)

 

 

9

 

 

 

V A Whyte

Company Secretary

 

2 February 2016

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKLLBBQLFZBBE

Companies

GSK (GSK)
UK 100

Latest directors dealings